RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Columbus, OH · +17 more sites
Multiple Sclerosis clinical trials in Columbus, OH
12 recruiting multiple sclerosis studies with a site in Columbus, OH.
RecruitingPhase 3NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Columbus, OH · +32 more sites
RecruitingPhase 3NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Columbus, OH · +24 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Columbus, OH · +50 more sites
RecruitingPhase 2NCT06782490
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Sponsor: Celgene
Cincinnati, OH · Columbus, OH · +13 more sites
RecruitingPhase 2NCT07840326
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Sponsor: Sundance Biosciences, Inc.
Columbus, OH · +2 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Centerville, OH · Cincinnati, OH · +106 more sites
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Cleveland, OH · Columbus, OH · +30 more sites
RecruitingPhase 1NCT06680037
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Sponsor: TG Therapeutics, Inc.
Cleveland, OH · Columbus, OH · +6 more sites
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Centerville, OH · Cincinnati, OH · Cleveland, OH · +41 more sites
RecruitingPhase 1 / Phase 2NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Sponsor: UniQure Biopharma B.V.
Cleveland, OH · Columbus, OH · +16 more sites
Not yet recruitingPhase 1NCT07270120
Senolytics for Secondary Progressive MS
Sponsor: Ohio State University
Columbus, OH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.